Navigation Links
VIB applies for second poplar field trial
Date:2/1/2013

Ghent, 1 February 2013. VIB has asked the federal government for a license to perform a second field trial with genetically modified poplars. The wood from these trees has a slightly different composition, meaning that it can be converted to sugars in a more efficient and more environmentally friendly manner. One of the aims of the field trial is to evaluate how the trees perform under realistic outdoor conditions. Another aim will be to expose the wood from the poplars to empirical conversion trials at a pilot factory scale. The field trial will take place at the ILVO Wetteren field trial site and falls under the "Ghent Bio-Economy" focal point of the University of Ghent.

The study framework

The field trial forms part of the research into options for using trees with an altered wood composition as a raw material for sustainable, bio-based products and bio-energy. Bio-plastics and biodegradable materials are currently made primarily using starch from crops such as corn. Alternatives are being sought to make the process more energy-efficient and to reserve fertile soil and food crops for food production. Trees may form an alternative, as their wood forms a possible raw material. Poplars have a number of interesting characteristics for this purpose: They grow quickly and they also grow well in boggy soil that is less suitable for food production.

Which genetic modification?

Wood consists primarily of three components: cellulose, hemi-cellulose and lignin. The first two components cellulose and hemi-cellulose are sugar polymers. These are the sugars that form the raw materials for the production of bio-plastics and biodegradable biomaterials. Bio-fuel can also be produced by means of fermentation. The third component lignin gives the wood more sturdiness. It must be degraded in order to release the sugar molecules. The degradation of lignin is technically complicated and an environmentally unfriendly process as a resul
'/>"/>

Contact: Kris Van der Beken
kris.vanderbeken@vib.be
32-473-783-435
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1 2

Related biology news :

1. Study reveals significance of second trimester markers for Downs syndrome
2. Second-hand smoke increases risk of invasive meningococcal disease in children
3. Developing second skin military fabric to repel chemical and biological agents
4. GOCEs second mission improving gravity map
5. Second most common infection in the US proving harder to treat with current antibiotics
6. Nanoengineers can print 3D microstructures in mere seconds
7. Dinosaur die-out might have been second of 2 closely timed extinctions
8. Evermedia Group Announces 375% Increase in Revenue for Second Quarter 2012
9. Aware, Inc. Reports Second Quarter 2012 Financial Results
10. NOAA plankton surveys, second longest in the North Atlantic, add to new global effort
11. U-M forecasters predict second-smallest Gulf of Mexico dead zone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/10/2015)...  Continuing its 167-year history of offering the Best, ... The Eye Scanning Password Authenticator , a device that ... websites or sensitive data. Employing the same ... the device has a small camera that scans and ... converting them into an encrypted ID that cannot be ...
(Date:3/10/2015)... 10, 2015  NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing ... wallet has been named the "Number One Best ... Rethink Modern ( http://www.rethinkmodern.com/ ) is a ... home and lifestyle that have a unique function or ...
(Date:3/3/2015)... March 3, 2015 Cryoport, Inc. ... advanced cryogenic logistics solutions for the life ... cells, cell lines, clinical research organizations, vaccine ... announced the expansion of its relationship with ... ("Fred Hutch") Clinical Research Division with the ...
Breaking Biology News(10 mins):Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
... Bacteria that generate significant amounts of electricity could be ... remote environments or to convert waste to electricity. Professor ... bacteria with large numbers of tiny projections called pili ... power in fuel cells than bacteria with a smooth ...
... British scientists have discovered two new genes associated ... The results, from the largest ever Alzheimer,s genome-wide association ... Nature Genetics . They are the first new genes ... Alzheimer,s disease since 1993. The Alzheimer,s Research Trust ...
... is available in French . A breakthrough ... and Denmark has uncovered a new gene that could lead ... a better understanding of how this widespread disease develops. ... diabetes, the new gene, called Insulin Receptor Substrate 1 (IRS1), doesn,t ...
Cached Biology News:Largest ever Alzheimer's genome study unveils dementia mysteries 2Largest ever Alzheimer's genome study unveils dementia mysteries 3Diabetes advance: Researchers find gene that causes resistance to insulin 2Diabetes advance: Researchers find gene that causes resistance to insulin 3
(Date:3/25/2015)... CAMBRIDGE, Mass. and REYKJAVIK, Iceland ... provides comprehensive capabilities for using the genome to create better ... publication of the largest studies of whole-genome data yet undertaken. ... Nature Genetics – are built around ... authored by a team of deCODE scientists led by ...
(Date:3/25/2015)... (PRWEB) March 25, 2015 Data ... Novel Mechanism of Action in Neuromuscular Diseases ... – Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication ... muscle troponin activator tirasemtiv in the journal Neurotherapeutics. ... IIa “Evidence of Effect” or hypothesis-generating clinical trial ...
(Date:3/25/2015)... the HAGUE, Netherlands , March 25, ... LES Stimulation therapy for chronic gastro-esophageal reflux disease (GERD) ... [ Surgery . 2015; 157(3):556-567 ], establishing ... therapy. The study included 25 patients ... years and taking prescribed daily proton pump inhibitor (PPI) ...
(Date:3/25/2015)... March 25, 2015  18 piglets born recently ... research by scientists in the College of Agriculture and ... a breakthrough in the field of genetic engineering. ... of Animal & Avian Sciences (ANSC) and Ki-Eun ... successfully produced genome-edited pigs using a recently developed, ...
Breaking Biology Technology:Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3University of Maryland Researchers Successfully Produce Genome-edited Pigs Using Revolutionary Technology 2
... - Trent 1000 engines have been selected, - New environmental partnership ... ... burn, SOUTH NORWALK, Conn., March 3 ... has selected,Rolls-Royce Trent 1000 engines to power its Boeing 787-9 fleet of ...
... LELYSTAD, Netherlands, March 3, Genmab A/S (OTC: GNMSF) ... collaboration aimed at identifying fully,human monoclonal antibodies against ... difficult to address using,commonly available technologies but are ... can for example be due to the,fact that ...
... Inc.,(Nasdaq: VRML ), a high-value molecular diagnostics ... exclusive license agreement with Stanford,University to develop and ... risk of peripheral artery disease (PAD). Estimated to ... serious condition that often goes,undiagnosed. The disease can ...
Cached Biology Technology:Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 2Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 3Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN 4Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 2Genmab and Pepscan to Identify Human Antibodies Against Intractable Targets 3Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 2Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk 3
Rabbit polyclonal to ZFP200 ( Abpromise for all tested applications). Antigen: Synthetic peptide: CGKSFNHKTNLNKHER (Human) Entrez Gene ID: 7752 Swiss Protein ID: P98182...
Human Ig Lambda-chain, clone ICO-16, Monoclonal Antibody...
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
WNV Core Antibody...
Biology Products: